<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33677642</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1619-7089</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of nuclear medicine and molecular imaging</Title><ISOAbbreviation>Eur J Nucl Med Mol Imaging</ISOAbbreviation></Journal><ArticleTitle>Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.</ArticleTitle><Pagination><StartPage>3187</StartPage><EndPage>3197</EndPage><MedlinePgn>3187-3197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00259-021-05294-3</ELocationID><Abstract><AbstractText Label="PURPOSE">The present study hypothesised that whole-body [18F]FDG-PET/CT might provide insight into the pathophysiology of long COVID.</AbstractText><AbstractText Label="METHODS">We prospectively enrolled 13 adult long COVID patients who complained for at least one persistent symptom for &gt;30&#xa0;days after infection recovery. A group of 26 melanoma patients with negative PET/CT matched for sex/age was used as controls (2:1 control to case ratio). Qualitative and semi-quantitative analysis of whole-body images was performed. Fisher exact and Mann-Whitney tests were applied to test differences between the two groups. Voxel-based analysis was performed to compare brain metabolism in cases and controls. Cases were further grouped according to prevalent symptoms and analysed accordingly.</AbstractText><AbstractText Label="RESULTS">In 4/13 long COVID patients, CT images showed lung abnormalities presenting mild [18F]FDG uptake. Many healthy organs/parenchyma SUVs and SUV ratios significantly differed between the two groups (p&#x2009;&#x2264;&#x2009;0.05). Long COVID patients exhibited brain hypometabolism in the right parahippocampal gyrus and thalamus (uncorrected p&#x2009;&lt;&#x2009;0.001 at voxel level). Specific area(s) of hypometabolism characterised patients with persistent anosmia/ageusia, fatigue, and vascular uptake (uncorrected p&#x2009;&lt;&#x2009;0.005 at voxel level).</AbstractText><AbstractText Label="CONCLUSION">[18F]FDG PET/CT acknowledged the multi-organ nature of long COVID, supporting the hypothesis of underlying systemic inflammation. Whole-body images showed increased [18F]FDG uptake in several "target" and "non-target" tissues. We found a typical pattern of brain hypometabolism associated with persistent complaints at the PET time, suggesting a different temporal sequence for brain and whole-body inflammatory changes. This evidence underlined the potential value of whole-body [18F]FDG PET in disclosing the pathophysiology of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sollini</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2214-6492</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morbelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7833-6095</Identifier><AffiliationInfo><Affiliation>Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccarelli</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8617-4153</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4376-6538</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aghemo</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0941-3226</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9555-5284</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiola</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3861-1248</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelardi</LastName><ForeName>Fabrizia</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7120-333X</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy. fabrizia.gelardi@st.hunimed.eu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy. fabrizia.gelardi@st.hunimed.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiti</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5806-1856</Identifier><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS, via Manzoni 56, 20089, Rozzano (Milan), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Milan, Pieve Emanuele, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Nucl Med Mol Imaging</MedlineTA><NlmUniqueID>101140988</NlmUniqueID><ISSNLinking>1619-7070</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain hypometabolism</Keyword><Keyword MajorTopicYN="N">Chronic COVID syndrome</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">[18F]FDG PET/CT</Keyword></KeywordList><CoiStatement>Dr. Sollini, Morbelli, Ciccarelli, Morelli, Aghemo and Gelardi have nothing to disclose; Dr. Cecconi reports personal fees from Edwards Lifesciences, personal fees from Directed Systems, and personal fees from Cheetah Medical, outside the submitted work; Dr. Chiti reports other from Sanofi, personal fees from AAA, personal fees from Blue Earth Diagnostics, and personal fees from General Electric Healthcare, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33677642</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pii">10.1007/s00259-021-05294-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Treglia G. Diagnostic performance of 18F-FDG PET/CT in infectious and inflammatory diseases according to published meta-analyses. Contrast Media Mol Imaging. Hindawi Ltd. and John Wiley and Sons, Inc.; 2019;2019:3018349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6683817</ArticleId><ArticleId IdType="pubmed">31427907</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Liu F, Yen TC, Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080035</ArticleId><ArticleId IdType="pubmed">32088847</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata S, Delgado Bolton RC, Kamani CH, Prior JO, Albano D, Bertagna F, et al. Role of 2-[18f]fdg as a radiopharmaceutical for pet/ct in patients with covid-19: a systematic review. Pharmaceuticals. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7696195</ArticleId><ArticleId IdType="pubmed">33182811</ArticleId></ArticleIdList></Reference><Reference><Citation>Living with Covid19. 2020.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. British Medical Journal Publishing Group; 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. Facing up to long COVID. Lancet. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nat Med. 2020;26:1803.</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, et al. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol Eur J Neurol. 2020;27:2651&#x2013;2657. doi: 10.1111/ene.14478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14478</ArticleId><ArticleId IdType="pmc">PMC7461074</ArticleId><ArticleId IdType="pubmed">32881133</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. Eur J Nucl Med Mol Imaging. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A, Soret M, Pyatigoskaya N, Habert M-O, Hesters A, Le Guennec L, et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. Eur J Nucl Med Mol Imaging. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. Springer; 2021;1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Xu S-B, Lin Y-X, Tian D, Zhu Z-Q, Dai F-H, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020;133:1039&#x2013;1043. doi: 10.1097/CM9.0000000000000774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000774</ArticleId><ArticleId IdType="pmc">PMC7147278</ArticleId><ArticleId IdType="pubmed">32118639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20:e276&#x2013;e288. doi: 10.1016/S1473-3099(20)30651-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30651-4</ArticleId><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection &#x2014; United Kingdom and United States, March&#x2013;August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1450&#x2013;1456. doi: 10.15585/mmwr.mm6940e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Frati P, et al. Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538370</ArticleId><ArticleId IdType="pubmed">33026628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647&#x2013;658. doi: 10.2967/jnumed.112.112524.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.112.112524</ArticleId><ArticleId IdType="pubmed">23359660</ArticleId></ArticleIdList></Reference><Reference><Citation>Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. RadioGraphics. 2005;25:1357&#x2013;1368. doi: 10.1148/rg.255045122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.255045122</ArticleId><ArticleId IdType="pubmed">16160116</ArticleId></ArticleIdList></Reference><Reference><Citation>Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2014:42, 328&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4315529</ArticleId><ArticleId IdType="pubmed">25452219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Slart RHJA. FDG-PET/CT(a) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250&#x2013;1269. doi: 10.1007/s00259-018-3973-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-018-3973-8</ArticleId><ArticleId IdType="pmc">PMC5954002</ArticleId><ArticleId IdType="pubmed">29637252</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YC, Hsu CC, Huang P, Yin TK, Chiu NT, Wang PW, et al. The changes in brain metabolism in people with activated brown adipose tissue: a PET study. Neuroimage. 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">20682349</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua C, Merchant TE, Li X, Li Y, Shulkin BL. Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children. J Nucl Med. 2015;56:575&#x2013;579. doi: 10.2967/jnumed.114.146993.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.114.146993</ArticleId><ArticleId IdType="pubmed">25745092</ArticleId></ArticleIdList></Reference><Reference><Citation>Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1994;2:189&#x2013;210. doi: 10.1002/hbm.460020402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.460020402</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Rosa PA, Cerami C, Gallivanone F, Prestia A, Caroli A, Castiglioni I, et al. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12:575&#x2013;593. doi: 10.1007/s12021-014-9235-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12021-014-9235-4</ArticleId><ArticleId IdType="pubmed">24952892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. Elsevier Inc.; 2014;48:193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">24582925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman MD, Cunningham WA. Type I and type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci. 2009;4:423&#x2013;428. doi: 10.1093/scan/nsp052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/scan/nsp052</ArticleId><ArticleId IdType="pmc">PMC2799956</ArticleId><ArticleId IdType="pubmed">20035017</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M, Raad N, Haseli S. 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol. 2020;27:1042&#x2013;1043. doi: 10.1016/j.acra.2020.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.04.030</ArticleId><ArticleId IdType="pmc">PMC7196385</ArticleId><ArticleId IdType="pubmed">32386948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764&#x2013;1777. doi: 10.1093/brain/awh526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh526</ArticleId><ArticleId IdType="pmc">PMC1939694</ArticleId><ArticleId IdType="pubmed">15888538</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini C, Morbelli S, Cistaro A, Campi C, Caponnetto C, Bauckneht M, et al. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis. Brain. 2018;141:2272&#x2013;2279. doi: 10.1093/brain/awy152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy152</ArticleId><ArticleId IdType="pmc">PMC6061793</ArticleId><ArticleId IdType="pubmed">30730551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Xu J, Chen L, Fu C, Kang Y, Zhang W, et al. Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging. Eur J Nucl Med Mol Imaging. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794623</ArticleId><ArticleId IdType="pubmed">33420914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chefer S, Thomasson D, Seidel J, Reba RC, Bohannon JK, Lackemeyer MG, et al. Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge. EJNMMI Res. 2015;5:65. doi: 10.1186/s13550-015-0143-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-015-0143-x</ArticleId><ArticleId IdType="pmc">PMC4646887</ArticleId><ArticleId IdType="pubmed">26573211</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50:54&#x2013;67. doi: 10.1007/s11239-020-02134-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02134-3</ArticleId><ArticleId IdType="pmc">PMC7225095</ArticleId><ArticleId IdType="pubmed">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis Springer. 2020:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373848</ArticleId><ArticleId IdType="pubmed">32700024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijl JP, Kwee TC, Slart RHJA, Yakar D, Wouthuyzen-Bakker M, Glaudemans AWJM. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia. Eur J Nucl Med Mol Imaging. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113205</ArticleId><ArticleId IdType="pubmed">33106925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahce I, Vos CG, Dickhoff C, Hartemink KJ, Dahele M, Smit EF, et al. Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC. Lung Cancer. 2014;85:205&#x2013;212. doi: 10.1016/j.lungcan.2014.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lungcan.2014.04.010</ArticleId><ArticleId IdType="pubmed">24854401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama T, Swanston N, Podoloff DA, Macapinlac HA. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging. 2005;32:1406&#x2013;1411. doi: 10.1007/s00259-005-1890-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-005-1890-0</ArticleId><ArticleId IdType="pubmed">16133379</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyall J, Johnson RF, Chefer S, Leyson C, Thomasson D, Seidel J, et al. [18F]-Fluorodeoxyglucose uptake in lymphoid tissue serves as a predictor of disease outcome in the nonhuman primate model of monkeypox virus infection. McFadden G, editor. J Virol. 2017;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5640857</ArticleId><ArticleId IdType="pubmed">28814515</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephen G. Baum M. Adult multisystem inflammatory syndrome associated with COVID-19. NEJM J Watch; 2020;2020.</Citation></Reference><Reference><Citation>Xiang YT, Yu X, Ungvari GS, Correll CU, Chiu HFK. Outcomes of SARS survivors in China: not only physical and psychiatric co-morbidities. East Asian Arch Psychiatr. 2014;24:37&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">24676486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. Cold Spring Harbor Laboratory Press; 2020;2020.10.19.20214494.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>